• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近期住院精神分裂症患者使用精神兴奋剂的情况。

Recent psychostimulant use in hospitalized schizophrenics.

作者信息

Richard M L, Liskow B I, Perry P J

出版信息

J Clin Psychiatry. 1985 Mar;46(3):79-83.

PMID:2857708
Abstract

The incidence of CNS stimulant use among 300 patients admitted to an acute care psychiatric facility was estimated to be 31% overall; 11% of patients admitted to use within 6 months of the index hospitalization. A number of previously described relationships between stimulant use and schizophrenia were confirmed. Relapsing schizophrenics utilized stimulants prior to hospitalization more often than nonschizophrenic patients; outpatient antipsychotic prophylaxis did not prevent these relapses. It is concluded that stimulants partially contribute to relapse in schizophrenics.

摘要

据估计,在一家急症护理精神病院收治的300名患者中,中枢神经系统兴奋剂的使用总体发生率为31%;11%的患者在首次住院后的6个月内开始使用。兴奋剂使用与精神分裂症之间的一些先前描述的关系得到了证实。复发型精神分裂症患者在住院前比非精神分裂症患者更常使用兴奋剂;门诊抗精神病药物预防并不能防止这些复发。得出的结论是,兴奋剂在一定程度上导致了精神分裂症患者的复发。

相似文献

1
Recent psychostimulant use in hospitalized schizophrenics.近期住院精神分裂症患者使用精神兴奋剂的情况。
J Clin Psychiatry. 1985 Mar;46(3):79-83.
2
[Schizophrenia and addiction: An evaluation of the self-medication hypothesis].[精神分裂症与成瘾:自我药疗假说的评估]
Encephale. 2003 May-Jun;29(3 Pt 1):193-203.
3
Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.依从药物治疗的精神分裂症门诊患者中的暴力行为:患病率及相关因素。
Acta Psychiatr Scand. 2009 Mar;119(3):218-25. doi: 10.1111/j.1600-0447.2008.01302.x.
4
Antipsychotic medication and length of stay at a psychiatric maximum-security unit in Norway (1987-2000).抗精神病药物与挪威一家高度设防精神病院的住院时长(1987 - 2000年)。
Nord J Psychiatry. 2006;60(2):132-6. doi: 10.1080/08039480600583662.
5
Substance abuse in clozapine-treated schizophrenic patients.
J Neuropsychiatry Clin Neurosci. 1997 Fall;9(4):626-7.
6
[Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].[双相情感障碍、精神分裂症及分裂情感性障碍中物质依赖共病的比较研究]
Encephale. 1996 Mar-Apr;22(2):95-101.
7
Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.药物滥用对慢性精神病患者幻觉发生率及治疗反应的影响。
J Clin Psychiatry. 1994 Sep;55(9):380-7.
8
A study of the pharmacologic treatment of medication-compliant schizophrenics who relapse.一项针对病情复发的依从药物治疗的精神分裂症患者的药物治疗研究。
J Clin Psychiatry. 1994 Nov;55(11):470-2.
9
Adjunctive desipramine in the treatment of cocaine abusing schizophrenics.辅助性地昔帕明治疗滥用可卡因的精神分裂症患者。
Psychopharmacol Bull. 1992;28(3):309-14.
10
Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.精神分裂症、分裂情感性障碍和精神病性心境障碍中急性利培酮反应的临床预测因素。
J Clin Psychiatry. 1995 Oct;56(10):466-70.

引用本文的文献

1
Daily Hassles and Health Among Persons with Severe Mental Disabilities.重度精神残疾者的日常困扰与健康状况
Psychosoc Rehabil J. 1993 Jan;16(3):27-40. doi: 10.1037/h0095677.
2
Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.莫达非尼治疗氯氮平治疗的精神分裂症患者:一项双盲、安慰剂对照的初步试验。
J Clin Psychiatry. 2009 Dec;70(12):1674-80. doi: 10.4088/JCP.08m04683. Epub 2009 Aug 11.
3
[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].[精神分裂症与共病物质使用障碍的药物治疗。一项系统评价]
Nervenarzt. 2008 Jan;79(1):17-8, 20-2, 24-6 passim. doi: 10.1007/s00115-007-2310-4.
4
Substance abuse and schizophrenia: pharmacotherapeutic intervention.药物滥用与精神分裂症:药物治疗干预
J Subst Abuse Treat. 2008 Jan;34(1):61-71. doi: 10.1016/j.jsat.2007.01.008. Epub 2007 Jun 15.
5
Dual diagnosis: HIV and mental illness, a population-based study.双重诊断:艾滋病毒与精神疾病,一项基于人群的研究。
Community Ment Health J. 2001 Dec;37(6):469-79. doi: 10.1023/a:1017577827658.
6
Private sector coverage of people with dual diagnoses.对双重诊断患者的私营部门保险覆盖情况。
J Ment Health Adm. 1996 Summer;23(3):317-28. doi: 10.1007/BF02522305.
7
Organizational guidelines for dual disorders programs.双相障碍项目的组织指南。
Psychiatr Q. 1998 Fall;69(3):145-68. doi: 10.1023/a:1022145125499.
8
Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence.精神分裂症与精神兴奋剂滥用:临床证据的综述与重新分析
Psychopharmacology (Berl). 1995 Oct;121(4):407-27. doi: 10.1007/BF02246489.
9
Detection of substance use disorders in severely mentally ill patients.
Community Ment Health J. 1993 Apr;29(2):175-92; discussion 193-4. doi: 10.1007/BF00756343.
10
Prevalence of alcohol and drug abuse in schizophrenic inpatients.精神分裂症住院患者中酒精和药物滥用的患病率。
Eur Arch Psychiatry Clin Neurosci. 1993;242(6):362-72. doi: 10.1007/BF02190250.